Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1995 Feb 28;92(5):1416–1420. doi: 10.1073/pnas.92.5.1416

Apoptosis and interleukin 7 gene expression in chronic B-lymphocytic leukemia cells.

B W Long 1, P L Witte 1, G N Abraham 1, S A Gregory 1, J M Plate 1
PMCID: PMC42530  PMID: 7877993

Abstract

mRNA for interleukin 7 (IL-7) was readily detected in leukemic cells immediately upon their removal from patients with chronic B-lymphocytic leukemia (B-CLL). IL-7 mRNA expression and IL-7 gene transcription were down regulated, however, when B-CLL cells were placed in culture at 37 degrees C for 4 hr. Down regulation of the IL-7 gene was prevented in cells maintained at 4 degrees C. Continued culture of B-CLL cells at 37 degrees C resulted in programmed cell death, or apoptosis, as evidenced by DNA fragmentation. The coincident kinetics of IL-7 gene down regulation and apoptosis suggested that IL-7 gene expression may be required for maintenance of CLL viability in vivo. Signals for IL-7 gene regulation and apoptosis induction were thus examined. Activation of normal B cells through their immunoglobulin receptors did not result in upregulation of IL-7 gene expression. Reagents required for CLL cell purification and culture also did not contribute to IL-7 gene regulation and apoptosis induction. IL-7 gene expression was retained and apoptosis was prevented, however, in CLL cells cultured on a monolayer of EA.hy926 human umbilical cord endothelial hybrid cells. Signals specifically presented by EA.hy926 cells supported both CLL cell viability and IL-7 gene expression, whereas culture of CLL cells on A549/8 carcinoma cells, the fusion partner used to generate the EA.hy926 cells, did not. Cell-cell contact was required, as culture supernatants did not prevent apoptosis. Specifically, IL-7 mRNA expression was retained and apoptosis was prevented only by contact with the endothelial cell hybrids. Preliminary data indicated that integrins expressed on CLL cells affected modulation of apoptosis and IL-7 gene regulation, suggesting that integrins may play significant roles in regulating viability of CLL cells.

Full text

PDF
1416

Images in this article

1417Fig. 1
on p.1417
1417Fig. 2
on p.1417
1417Fig. 3
on p.1417
1418Fig. 4
on p.1418
1418Fig. 5
on p.1418
1419Fig. 6
on p.1419
1419Fig. 7
on p.1419

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armitage R. J., Namen A. E., Sassenfeld H. M., Grabstein K. H. Regulation of human T cell proliferation by IL-7. J Immunol. 1990 Feb 1;144(3):938–941. [PubMed] [Google Scholar]
  2. Benjamin D., Sharma V., Knobloch T. J., Armitage R. J., Dayton M. A., Goodwin R. G. B cell IL-7. Human B cell lines constitutively secrete IL-7 and express IL-7 receptors. J Immunol. 1994 May 15;152(10):4749–4757. [PubMed] [Google Scholar]
  3. Buschle M., Campana D., Carding S. R., Richard C., Hoffbrand A. V., Brenner M. K. Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med. 1993 Jan 1;177(1):213–218. doi: 10.1084/jem.177.1.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chan I. T., Limmer A., Louie M. C., Bullock E. D., Fung-Leung W. P., Mak T. W., Loh D. Y. Thymic selection of cytotoxic T cells independent of CD8 alpha-Lck association. Science. 1993 Sep 17;261(5128):1581–1584. doi: 10.1126/science.8372352. [DOI] [PubMed] [Google Scholar]
  5. Collins R. J., Verschuer L. A., Harmon B. V., Prentice R. L., Pope J. H., Kerr J. F. Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. Br J Haematol. 1989 Mar;71(3):343–350. doi: 10.1111/j.1365-2141.1989.tb04290.x. [DOI] [PubMed] [Google Scholar]
  6. Dalloul A., Laroche L., Bagot M., Mossalayi M. D., Fourcade C., Thacker D. J., Hogge D. E., Merle-Béral H., Debré P., Schmitt C. Interleukin-7 is a growth factor for Sézary lymphoma cells. J Clin Invest. 1992 Sep;90(3):1054–1060. doi: 10.1172/JCI115920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dancescu M., Rubio-Trujillo M., Biron G., Bron D., Delespesse G., Sarfati M. Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression. J Exp Med. 1992 Nov 1;176(5):1319–1326. doi: 10.1084/jem.176.5.1319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Digel W., Schmid M., Heil G., Conrad P., Gillis S., Porzsolt F. Human interleukin-7 induces proliferation of neoplastic cells from chronic lymphocytic leukemia and acute leukemias. Blood. 1991 Aug 1;78(3):753–759. [PubMed] [Google Scholar]
  9. Edgell C. J., McDonald C. C., Graham J. B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A. 1983 Jun;80(12):3734–3737. doi: 10.1073/pnas.80.12.3734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Foss F. M., Koc Y., Stetler-Stevenson M. A., Nguyen D. T., O'Brien M. C., Turner R., Sausville E. A. Costimulation of cutaneous T-cell lymphoma cells by interleukin-7 and interleukin-2: potential autocrine or paracrine effectors in the Sézary syndrome. J Clin Oncol. 1994 Feb;12(2):326–335. doi: 10.1200/JCO.1994.12.2.326. [DOI] [PubMed] [Google Scholar]
  11. Fournier S., Jackson J., Kumar A., King T., Sharma S., Biron G., Rubio M., Delespesse G., Sarfati M. Low-molecular weight B cell growth factor (BCGF-12KD) as an autocrine growth factor in B cell chronic lymphocytic leukemia. Eur J Immunol. 1992 Jul;22(7):1927–1930. doi: 10.1002/eji.1830220737. [DOI] [PubMed] [Google Scholar]
  12. Fraser C. C., Thacker J. D., Hogge D. E., Fatur-Saunders D., Takei F., Humphries R. K. Alterations in lymphopoiesis after hematopoietic reconstitution with IL-7 virus-infected bone marrow. J Immunol. 1993 Sep 1;151(5):2409–2418. [PubMed] [Google Scholar]
  13. Frishman J., Long B., Knospe W., Gregory S., Plate J. Genes for interleukin 7 are transcribed in leukemic cell subsets of individuals with chronic lymphocytic leukemia. J Exp Med. 1993 Apr 1;177(4):955–964. doi: 10.1084/jem.177.4.955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Goodwin R. G., Lupton S., Schmierer A., Hjerrild K. J., Jerzy R., Clevenger W., Gillis S., Cosman D., Namen A. E. Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells. Proc Natl Acad Sci U S A. 1989 Jan;86(1):302–306. doi: 10.1073/pnas.86.1.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gordon J., Cairns J. A. Autocrine regulation of normal and malignant B lymphocytes. Adv Cancer Res. 1991;56:313–334. doi: 10.1016/s0065-230x(08)60484-4. [DOI] [PubMed] [Google Scholar]
  16. Heslop H. E., Hoffbrand A. V., Brenner M. K. TNF and chronic B lymphoproliferative disorders. Leukemia. 1993 Sep;7(9):1476–1476. [PubMed] [Google Scholar]
  17. Kay N. E., Burton J., Wagner D., Nelson D. L. The malignant B cells from B-chronic lymphocytic leukemia patients release TAC-soluble interleukin-2 receptors. Blood. 1988 Aug;72(2):447–450. [PubMed] [Google Scholar]
  18. Koopman G., Keehnen R. M., Lindhout E., Newman W., Shimizu Y., van Seventer G. A., de Groot C., Pals S. T. Adhesion through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells. J Immunol. 1994 Apr 15;152(8):3760–3767. [PubMed] [Google Scholar]
  19. Lee G., Namen A. E., Gillis S., Ellingsworth L. R., Kincade P. W. Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-beta. J Immunol. 1989 Jun 1;142(11):3875–3883. [PubMed] [Google Scholar]
  20. Lotz M., Ranheim E., Kipps T. J. Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells. J Exp Med. 1994 Mar 1;179(3):999–1004. doi: 10.1084/jem.179.3.999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Mercolino T. J., Arnold L. W., Haughton G. Phosphatidyl choline is recognized by a series of Ly-1+ murine B cell lymphomas specific for erythrocyte membranes. J Exp Med. 1986 Jan 1;163(1):155–165. doi: 10.1084/jem.163.1.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Muegge K., Vila M. P., Durum S. K. Interleukin-7: a cofactor for V(D)J rearrangement of the T cell receptor beta gene. Science. 1993 Jul 2;261(5117):93–95. doi: 10.1126/science.7686307. [DOI] [PubMed] [Google Scholar]
  23. Nakayama K., Nakayama K., Negishi I., Kuida K., Shinkai Y., Louie M. C., Fields L. E., Lucas P. J., Stewart V., Alt F. W. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science. 1993 Sep 17;261(5128):1584–1588. doi: 10.1126/science.8372353. [DOI] [PubMed] [Google Scholar]
  24. Naume B., Gately M., Espevik T. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells. J Immunol. 1992 Apr 15;148(8):2429–2436. [PubMed] [Google Scholar]
  25. Pinto A., Del Vecchio L., Carbone A., Roncadin M., Volpe R., Serraino D., Monfardini S., Colombatti A., Zagonel V. Expression of myelomonocytic antigens is associated with unfavourable clinicoprognostic factors in B-cell chronic lymphocytic leukaemia. Ann Oncol. 1991 Feb;2 (Suppl 2):107–113. doi: 10.1007/978-1-4899-7305-4_17. [DOI] [PubMed] [Google Scholar]
  26. Plate J. M., Knospe W. H., Harris J. E., Gregory S. A. Normal and aberrant expression of cytokines in neoplastic cells from chronic lymphocytic leukemias. Hum Immunol. 1993 Apr;36(4):249–258. doi: 10.1016/0198-8859(93)90132-k. [DOI] [PubMed] [Google Scholar]
  27. Pritsch O., Magnac C., Dumas G., Egile C., Dighiero G. V gene usage by seven hybrids derived from CD5+ B-cell chronic lymphocytic leukemia and displaying autoantibody activity. Blood. 1993 Nov 15;82(10):3103–3112. [PubMed] [Google Scholar]
  28. Rich B. E., Campos-Torres J., Tepper R. I., Moreadith R. W., Leder P. Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice. J Exp Med. 1993 Feb 1;177(2):305–316. doi: 10.1084/jem.177.2.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ruoslahti E., Reed J. C. Anchorage dependence, integrins, and apoptosis. Cell. 1994 May 20;77(4):477–478. doi: 10.1016/0092-8674(94)90209-7. [DOI] [PubMed] [Google Scholar]
  30. Sarfati M. Interleukin-4 and the two isoforms of CD23 antigen: their possible contribution to the physiopathology of chronic lymphocytic leukemia disease. Nouv Rev Fr Hematol. 1993 Apr;35(2):109–113. [PubMed] [Google Scholar]
  31. Semenzato G., Foa R., Agostini C., Zambello R., Trentin L., Vinante F., Benedetti F., Chilosi M., Pizzolo G. High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia. Blood. 1987 Aug;70(2):396–400. [PubMed] [Google Scholar]
  32. Sthoeger Z. M., Wakai M., Tse D. B., Vinciguerra V. P., Allen S. L., Budman D. R., Lichtman S. M., Schulman P., Weiselberg L. R., Chiorazzi N. Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med. 1989 Jan 1;169(1):255–268. doi: 10.1084/jem.169.1.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Takeuchi H., Katayama I. Surface phenotype and adhesion activity of B-cell chronic lymphoid leukemias. Leuk Lymphoma. 1993 Jun;10(3):209–216. doi: 10.3109/10428199309145885. [DOI] [PubMed] [Google Scholar]
  34. Tsuda H., Matsumi S., Nishimura H., Kawano F., Shido T., Takatsuki K. Myelo-monocytoid immunophenotypes of B-cell chronic lymphocytic leukemia cells. Intern Med. 1993 Jul;32(7):533–539. doi: 10.2169/internalmedicine.32.533. [DOI] [PubMed] [Google Scholar]
  35. Witte P. L., Frantsve L. M., Hergott M., Rahbe S. M. Cytokine production and heterogeneity of primary stromal cells that support B lymphopoiesis. Eur J Immunol. 1993 Aug;23(8):1809–1817. doi: 10.1002/eji.1830230812. [DOI] [PubMed] [Google Scholar]
  36. Wyllie A. H., Kerr J. F., Currie A. R. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251–306. doi: 10.1016/s0074-7696(08)62312-8. [DOI] [PubMed] [Google Scholar]
  37. van Kooten C., Rensink I., Aarden L., van Oers R. Cytokines and intracellular signals involved in the regulation of B-CLL proliferation. Leuk Lymphoma. 1993 Dec;12(1-2):27–33. doi: 10.3109/10428199309059568. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES